Pharmafile Logo
Pharmafocus logo
Advanced Search
sanofi_hq__boetie_hall_web

Sanofi and GSK’s COVID-19 vaccine shows promising results in Phase II trial

May 17, 2021
Sales and Marketing

The adjuvanted recombinant COVID-19 vaccine produced by Sanofi and GSK has demonstrated strong immune responses across all adult age groups …

News

Oxford University to collaborate with Oracle on COVID variant research

May 17, 2021
Sales and Marketing AI, COVID-19, Oxford, variants

In response to emerging variants of COVID-19, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS), combining …

News

PrecisionLife & Cyclica join forces on 30 AI drug discovery programmes

May 17, 2021
Sales and Marketing AI, drug discovery

PrecisionLife, a combinatorial analytics company, and Toronto-based drug discovery company, Cyclica, have announced a strategic partnership to co-market and offer …

News
biogen_austria_238

Biogen fails to meet primary endpoint in XLRP study

May 17, 2021
Sales and Marketing Biogen, Clinical Trail

Biogen have released topline results from its Phase2/3 Xirius study of cotoretigene toliparvovec (BIIB112) as a gene therapy for patients …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

May 14, 2021
Medical Communications

Among our ten most-read stories this week: India recoded its record number of COVID-19 deaths, with 4,205 fatalities confirmed in …

News

MSD’s colorectal cancer treatment approved by NICE

May 14, 2021
Medical Communications

Pembrolizumab (Keytruda), for people with untreated metastatic colorectal cancer who have specific mutations in their cancer cells, has been approved …

News
Pfizer sign

Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows

May 14, 2021
Medical Communications COVID-19, COVID-19 vaccine, Pfizer vaccine, pfizer-biontech vaccine, pharma, pharma news

The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed 12 weeks apart, a Birmingham …

News
biogen_austria_238

Biogen to collaborate with Envisagenics on RNA splicing research

May 14, 2021
Medical Communications AI

Biogen and Envisagenics have announced a new collaboration to advance ribonucleic acid (RNA) splicing research within central nervous system (CNS) …

News

Major ovarian cancer screening trial fails to reduce deaths

May 14, 2021
Medical Communications

A major trial involving 200,000 women to detect ovarian cancer has failed to save lives after two decades of work. …

News

India approves Covaxin clinical trials for children aged 2-18 years old

May 13, 2021

The Drugs Controller General of India (DCGI) has cleared Bharat Biotech’s Covaxin trials on children from 2-18 years old. The …

News
Amgen flag

AstraZeneca and Amgen asthma drug shows positive results in Phase III trial

May 13, 2021
Amgen, AstraZeneca, asthma, asthma treatment, pharma, pharma news, severe asthma

AstraZeneca and Amgen’s new tezepelumab drug for the treatment of severe asthma has shown superiority across all primary and secondary …

News
sanofi_hq__boetie_hall_web

Sanofi’s Libtayo shows positive Phase III results in advanced cervical cancer

May 13, 2021
Libtayo, Sanofi, cemiplimab, cervical cancer

Regeneron Pharmaceuticals and Sanofi have announced today positive Phase III trial results investigating the PD-1 inhibitor Libtayo (cemiplimab) in patients …

News

Rinri Therapeutics secures £3.2 million grant for hearing loss therapy

May 13, 2021
Stem cells

Sheffield-based biotech company, Rinri Therapeutics, have secured a £3.2 million grant from Innovate UK to further develop Rinri’s novel stem …

News

Exscientia launch trial of third AI-designed molecule

May 13, 2021
AI, Altzeimer's, Exscientia

Exscientia has launched Phase I trials in the US of DSP-0038 for the treatment of Alzheimer’s disease psychosis, the third …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

May 12, 2021
Research and Development COVID-19

The past week has seen India’s highest number of COVID-19 deaths, with 4,205 fatalities in a single day. There has …

News

India report record number of COVID deaths as bodies drift down Ganges

May 12, 2021
Research and Development COVID-19, India, Indian COVID crisis, covid 19 news, covid-19 news, pharma, pharma news

India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 fatalities officially confirmed.

News
MHRA sign

Astellas prostate cancer drug gets third approval from MHRA

May 12, 2021
Research and Development Astellas, MHRA, cancer research, cancer treatment, pharma, pharma news, prostate cancer

The MHRA has approved Astellas Pharma’s XTANDI (enzalutamide) drug for the treatment of a third form of prostate cancer, making …

News

NICE rejects Pfizer’s Vyndaqel for treating rare heart condition

May 12, 2021
Research and Development NICE, Pfizer, Vyandaqel

NICE has published final guidance today which rejects tafamidis, also known as Vyndaqel, for treating rare heart condition transthyretin amyloidosis …

News

Endogena’s retinitis pigmentosa treatment granted Orphan Drug Designation by FDA

May 12, 2021
Research and Development DFA, Endogena, Orphan Drug Designation

Endogena Therapeutics Inc has been granted Orphan Drug Designation for its EA-2353 ophthalmic suspension targeting retinitis pigmentosa by the FDA. …

News

Eli Lilly and MiNA Therapeutics to collaborate on saRNA research

May 12, 2021
Research and Development Eli Lilly

Eli Lilly and MiNA Therapeutics have announced a global research collaboration to develop novel drug candidates using MiNA’s proprietary small …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025